Amyotrophic Lateral Sclerosis (ALS) Treatment; U.S. FDA Has Approved Five Drugs to Treat ALS and Its Symptoms

 

Amyotrophic Lateral Sclerosis (ALS) Treatment 

Amyotrophic lateral sclerosis (ALS) treatment depends on stage of the disease. Medication and therapy can slow ALS and reduce discomfort, but there's no cure for ALS. Amyotrophic lateral sclerosis, or ALS, is a progressive nervous system disease that affects nerve cells in the brain and spinal cord, causing loss of muscle control. ALS is also described by how it starts. Rapid-onset ALS has symptoms that appear quickly. Bulbar-onset ALS starts with trouble swallowing or speaking. Limb-onset ALS starts with symptoms in arms or legs.

According to Coherent market Insights the Global Amyotrophic Lateral Sclerosis (ALS) Treatment Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028.

The first sign of amyotrophic lateral sclerosis usually appears in the hand or arm and can show as difficulty with simple tasks such as buttoning a shirt, writing, or turning a key in a lock. In some cases, signs and symptoms initially affect one leg. Most people who develop amyotrophic lateral sclerosis (ALS) are between the ages of 40 and 70, with an average age of 55 at the time of diagnosis. However, ALS do occur in individuals in their twenties and thirties. Moreover, ALS is 20% more common in men than women.

Signs and symptoms of ALS vary greatly from person to person, depending on which neurons are affected. Amyotrophic lateral sclerosis (ALS) treatment includes medications and therapies to manage signs and symptoms and slow the progress of the disease. However, treatments can’t reverse the damage of ALS, but can prevent complications, slow the progression of symptoms, and make people more comfortable and independent. ALS treatment help control symptoms and make living with the disease easier.

The U.S. Food and Drug Administration (FDA) has approved five drugs to for the amyotrophic lateral sclerosis (ALS) treatment, such as Rilutek, Radicava, Tiglutik, Nuedexta, and Exservan. Riluzole (Rilutek), an oral medication that has been shown to slow the course of the disease and extend survival in ALS patients, and Edaravone (Radicava), a medication that helps slow the progression of ALS in the early stages.